Literature DB >> 3517854

Cloning, sequence, and expression of bovine interleukin 2.

D P Cerretti, K McKereghan, A Larsen, M A Cantrell, D Anderson, S Gillis, D Cosman, P E Baker.   

Abstract

Interleukin 2 (IL-2) cDNA clones have been isolated from both human and murine sources. We report here the isolation of a cDNA clone encoding bovine IL-2. This was accomplished by screening a cDNA library constructed from lectin-stimulated bovine lymph node cells, using a human IL-2 probe. Bovine IL-2 is composed of 155 amino acids and has a predicted molecular weight of 19,555. Alignment of the amino acid sequence with human IL-2 indicates that mature bovine IL-2 is composed of 135 amino acids and has a predicted molecular weight of 15,452. It has an amino acid homology of 65% with human IL-2 and 50% with murine IL-2. Bovine IL-2 is unique among IL-2 homologs in that it has a single N-linked glycosylation site. Biologically active bovine IL-2 was synthesized in an Escherichia coli expression system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3517854      PMCID: PMC323485          DOI: 10.1073/pnas.83.10.3223

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels.

Authors:  B R Oakley; D R Kirsch; N R Morris
Journal:  Anal Biochem       Date:  1980-07-01       Impact factor: 3.365

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2.

Authors:  M A Cheever; P D Greenberg; A Fefer
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

5.  Bovine T lymphocytes. I. Generation and maintenance of an interleukin-2-dependent, cytotoxic T-lymphocyte cell line.

Authors:  K S Picha; P E Baker
Journal:  Immunology       Date:  1986-01       Impact factor: 7.397

6.  Generation of cytotoxic lymphocytes to syngeneic tumors by using co-stimulator (Interleukin 2): in vivo activity.

Authors:  G B Mills; G Carlson; V Paetkau
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Bovine costimulator. II. Generation and maintenance of a bovine costimulator-dependent bovine lymphoblastoid cell line.

Authors:  P E Baker; K F Knoblock
Journal:  Vet Immunol Immunopathol       Date:  1982-07       Impact factor: 2.046

9.  Construction of a general vector for efficient expression of mammalian proteins in bacteria: use of a synthetic ribosome binding site.

Authors:  G Jay; G Khoury; A K Seth; E Jay
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

10.  Structure and expression of a cloned cDNA for human interleukin-2.

Authors:  T Taniguchi; H Matsui; T Fujita; C Takaoka; N Kashima; R Yoshimoto; J Hamuro
Journal:  Nature       Date:  1983 Mar 24-30       Impact factor: 49.962

View more
  17 in total

1.  cDNA cloning of ovine interleukin 2 by PCR.

Authors:  J C Goodall; D C Emery; A C Perry; L S English; L Hall
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

2.  The molecular cloning of ovine interleukin 2 gene by the polymerase chain reaction.

Authors:  H F Seow; J S Rothel; A J Radford; P R Wood
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

3.  Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropin-class lytic peptide in transgenic mice and subsequent resistance to Brucella abortus.

Authors:  W A Reed; P H Elzer; F M Enright; J M Jaynes; J D Morrey; K L White
Journal:  Transgenic Res       Date:  1997-09       Impact factor: 2.788

4.  Babesia bovis rhoptry-associated protein 1 is immunodominant for T helper cells of immune cattle and contains T-cell epitopes conserved among geographically distant B. bovis strains.

Authors:  W C Brown; T F McElwain; B J Ruef; C E Suarez; V Shkap; C G Chitko-McKown; W Tuo; A C Rice-Ficht; G H Palmer
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  Sequence of rat interleukin 2 and anomalous binding of a mouse interleukin 2 cDNA probe to rat MHC class II-associated invariant chain mRNA.

Authors:  A J McKnight; D W Mason; A N Barclay
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

6.  Insufficient (sub-native) helix content in soluble/solid aggregates of recombinant and engineered forms of IL-2 throws light on how aggregated IL-2 is biologically active.

Authors:  Uzma Fatima; Balvinder Singh; Karthikeyan Subramanian; Purnananda Guptasarma
Journal:  Protein J       Date:  2012-10       Impact factor: 2.371

7.  IL-2-like activity in lymph fluid following in vivo antigen challenge.

Authors:  R Bujdoso; P Young; J Hopkins; I McConnell
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

8.  An examination of the generation-time effect on molecular evolution.

Authors:  T Ohta
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

9.  Existence of at least five interleukin-2 molecules in different mouse strains.

Authors:  F Matesanz; A Alcina; A Pellicer
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

10.  CD4+ T-helper lymphocyte responses against Babesia bigemina rhoptry-associated protein I.

Authors:  S D Rodríguez; G H Palmer; T F McElwain; T C McGuire; B J Ruef; M G Chitko-McKown; W C Brown
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.